Skip to main content

Novo Nordisk projects weaker sales as it battles copycat drugs

Novo Nordisk said it expects weaker sales growth of its popular weight-loss drug Wegovy due to competition from copycat drugs.

from Us - CBSNews.com https://ift.tt/eWOf0jb
via IFTTT

Comments

Popular posts from this blog